2009Expert Opinion on Investigational DrugsRequires access

Antiretroviral drugs in development. A report from HIV DART 2008: frontiers in drug development for antiretroviral therapies

Zelalem Temesgen

Open publisher page 1 citations

Abstract

HIV DART 2008, Frontiers in Drug Development for Antiretroviral Therapies, was held on 9-12 December 2008 in Puerto Rico. The stated purpose of this biannual international meeting is to assemble clinicians, researchers and basic scientists together to advance the knowledge of the ongoing drug development processes in antiretroviral research. However, there were also presentations of thematic reviews of clinical topics such as prevention and drug resistance; HIV therapy in developing countries; and HIV/hepatitis and other coinfections. This report focuses on the main theme of the conference, the antiretroviral drug development pipeline. The author is solely responsible for the selection of topics and presentations to be included in this report.

About this research paper

What this paper is about

HIV DART 2008, Frontiers in Drug Development for Antiretroviral Therapies, was held on 9-12 December 2008 in Puerto Rico. The stated purpose of this biannual international meeting is to assemble clinicians, researchers and basic scientists together to advance the knowledge of the ongoing drug development processes in antiretroviral research. However, there were also presentations of thematic reviews of clinical topics such as prevention and drug resistance; HIV therapy in developing countries; and HIV/hepatitis and other coinfections. This report focuses on the main theme of the conference, the antiretroviral drug development pipeline. The author is solely responsible for the selection of topics and presentations to be included in this report.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

HIV DART 2008, Frontiers in Drug Development for Antiretroviral Therapies, was held on 9-12 December 2008 in Puerto Rico. The stated purpose of this biannual international meeting is to assemble clinicians, researchers and basic scientists together to advance the knowledge of the ongoing drug development processes in antiretroviral research. However, there were also presentations of thematic reviews of clinical topics such as prevention and drug resistance; HIV therapy in developing countries; and HIV/hepatitis and other coinfections. This report focuses on the main theme of the conference, the antiretroviral drug development pipeline. The author is solely responsible for the selection of topics and presentations to be included in this report.

Key concepts: Antiretroviral drug, Human immunodeficiency virus (HIV), Antiretroviral therapy, Medicine, Drug development, ANTIRETROVIRAL AGENTS, Drug, Family medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Antiretroviral drugs in development. A report from HIV DART 2008: frontiers in drug development for antiretroviral therapies — Research Paper | ScholarLens